(1)
Salimah, K.; Hardianti, M. S.; Anggorowati, N.; Taroeno-Hariadi, K. Co-Expression of BCL2 and C-MYC As a Potential Predictive Factor of Survival in Diffuse Large B Cell Lymphoma With Rituximab-Based Chemotherapy. apjcb 2026, 11, 23-29.